Medical/Pharmaceuticals

Publication in The New England Journal of Medicine Confirms that Tens of Thousands of Women with Node-positive, Early-stage Breast Cancer Can Avoid Chemotherapy with the Oncotype DX® Test

- RxPONDER, an independent study led by SWOG Cancer Research Network, demonstrates that guiding treatment with Oncotype DX test can spare chemotherapy use in majority of postmenopausal women - Results have already led to updated NCCN Guidelines® for breast cancer - New RxPONDER results to be fea...

2021-12-02 16:00 2477

DiNovA Medtech Announces Mr. Yaniv Kirma to Join as DiNovA Israel Incubator's Chief Operating Officer

CAESAREA, Israel, Dec. 2, 2021 /PRNewswire/ -- DiNovA Medtech, a leading medical devices incubator inChina ("DiNovA"), is pleased to announce Mr. Yaniv Kirma, to come on board as Chief Operating Officer of DiNovA Israel Incubator ("DiNovA Israel"). Mr. Kirma will join force with Chief Medical Off...

2021-12-02 16:00 1293

DoctorOnCall Partners Up With Qualitas Group to Bolster Booster Vaccination Drive

KUALA LUMPUR, Malaysia, Dec. 2, 2021 /PRNewswire/ -- DoctorOnCall, Malaysia's first and largest digital health platform today announced its partnership with Qualitas Medical Group to form a collaborative alliance to extendCOVID-19 vaccination to the population who are yet to receive it, including...

2021-12-02 15:12 2454

P&G Health commemorates Iron Deficiency Day with the launch of the 'First Iron Deficiency Diagnosis and Counselling Guide' for Pharmacists

* Southeast Asia and Africa continue to report the highest prevalence rates of anemia, accounting for 85 percent of global reported cases. * Launched in conjunction with Iron Deficiency Day 2021, the guide with its novel 4-step framework will equip pharmacists with a structured guide to better...

2021-12-02 14:03 2033

CCTV+: Peng Liyuan sends best wishes to students with HIV on World AIDS Day

BEIJING, Dec. 2, 2021 /PRNewswire/ -- On the occasion of the 34th World AIDS Day Wednesday, Peng Liyuan, wife of Chinese President Xi Jinping, sent her best wishes to students in the Linfen Red Ribbon School in northChina's Shanxi Province, the only facility set up in the country specifically for...

2021-12-02 13:58 2128

TOT BIOPHARM Announces NMPA Granted Marketing Approval for Pusintin® (TAB008, Bevacizumab Injection) in China

SUZHOU, China, Dec. 2, 2021 /PRNewswire/ -- TOT BIOPHARM International Company Limited (TOT BIOPHARM, 1875.HK) announced its self-developed Pusintin® (TAB008, bevacizumab injection) has been officially granted approval by the National Medical Products Administration ("NMPA") for marketing in main...

2021-12-02 08:00 2246

SOPHiA GENETICS Announces Launch of DEEP-Lung-IV Multimodal Clinical Study

Study to leverage deep learning-enabled analysis of the aggregation of real-world multimodal data to validate predictive signatures associated with response to immunotherapy and prognosis of patients with stage IV non-small cell lung cancer Large-scale, multicentric real-world study aims to enro...

2021-12-02 02:30 1728

Fifty percent recruitment milestone for PROPELLER prostate cancer trial

SYDNEY, Dec. 1, 2021 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company developing next-generation products to address the growing needs in oncology, is pleased to announce that 15 of 30 participants have been recruited in the diagnostic64...

2021-12-01 21:57 1437

Licensing Partner of Shenzhen Chipscreen Biosciences - HUYABIO International, Receives Regulatory Approval for Chidamide Monotherapy of Peripheral T-Cell Lymphoma(PTCL) in Japan

SHENZHEN, China, Dec. 1, 2021 /PRNewswire/ -- Shenzhen Chipscreen Biosciences' licensing partner, HUYABIO International (HUYABIO™), today announced the regulatory approval for Chidamide (Tucidinostat, also known as Epidaza ®, Hiyasta®, HBI-8000) monotherapy for the treatment of relapsed or refrac...

2021-12-01 21:54 1628

When and How to Screen for Colorectal Cancer? New NCCN Patient Guideline Explains Latest Timing and Approaches

PLYMOUTH MEETING, Pa., Dec. 1, 2021 /PRNewswire/ -- The National Comprehensive Cancer Network (NCCN®) today announced the publication of new NCCN Guidelines for Patients®: Colorectal Cancer Screening. Colorectal cancer (CRC) is the fourth most frequently diagnosed cancer inthe United States, with...

2021-12-01 21:37 1770

U.S. FDA Grants Bionomics Fast Track Designation to BNC210 for the Acute Treatment of Social Anxiety Disorder and Other Anxiety Related Disorders

ADELAIDE, Australia, Dec. 1, 2021 /PRNewswire/ -- Bionomics Limited (ASX:BNO, OTCQB:BNOEF) (Bionomics or Company), a clinical-stage biopharmaceutical company, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the BNC210 development progr...

2021-12-01 19:00 2284

VIRALEZE™ antiviral nasal spray registered in Vietnam with launch to follow this week

MELBOURNE, Australia, Dec. 1, 2021 /PRNewswire/ -- Australian biotech company Starpharma  today announced that its broad spectrum antiviral nasal spray, VIRALEZE™, has been registered for sale inVietnam, with the product scheduled to launch inVietnam this week. VIRALEZE™...

2021-12-01 16:40 1667

Dawn Health set out to revolutionize digitalization of the global life science industry with new investment round

COPENHAGEN, Denmark, Dec. 1, 2021 /PRNewswire/ -- Dawn Health, a global leader in digital health, has received aUSD 25 million investment from a consortium of highly experienced investors. The consortium counts Chr. Augustinus Fabrikker, Vaekstfonden - The Danish Growth Fund, and Lars Marcher. Th...

2021-12-01 16:35 1449

World Federation of Neurology Impresses Importance of Brain Health Through Global Public Initiative

LONDON, Dec. 1, 2021 /PRNewswire/ -- The World Federation of Neurology (WFN) is leading the charge on advocating for brain health awareness, through the launch of its Brain Health Initiative (BHI), a program created to reduce the immense global burden of brain diseases and disorders. Neurological...

2021-12-01 16:22 1642

Great Bay Bio Completes a Near USD 10M Series A Fundraising

HONG KONG, Dec. 1, 2021 /PRNewswire/ -- Great Bay Bio (hereinafter referred to as "GBB") is pleased to announce today the completion of its nearUSD 10M series A fundraising led by Proxima Ventures. The round was oversubscribed and upsized with participation by many new and existing institutional ...

2021-12-01 15:00 1653

Harrison.ai raises AUD$129 million and partners with Sonic Healthcare to develop pathology AI, accelerating its mission to expand capacity of global healthcare

$129 million funding raised from global venture firms and strategic investors including Horizons Ventures, I-MED Radiology and Sonic Healthcare in one of Australia's largest Series B funding rounds ever New pathology Joint Venture combines Harrison.ai's expertise in clinical artificial intelligen...

2021-12-01 13:01 1653

GenScript and BioComo Join Forces to Accelerate Novel Intranasal SARS-CoV-2 Vaccine Development in Japan

TOKYO and SINGAPORE, Dec. 1, 2021 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a leading global biotechnology company, and BioComo Incorporation, a drug discovery venture based in Mie prefecture,Japan, today announces a strategic agreement for joint research a...

2021-12-01 12:03 3642

Binhai New Area to spearhead China's medical industry development

TIANJIN, China, Nov. 30, 2021 /PRNewswire/ -- Here's a news report from chinadaily.com.cn: By 2025, the Binhai New Area in North China's Tianjin municipality will cultivate industry clusters worth tens of billions of yuan that are dedicated to pharmaceuticals, biotech, medical devices, diagnosti...

2021-12-01 11:20 1283

Sai Life Sciences' pharmaceutical API manufacturing site receives Certificate of Inspection from PMDA, Japan

HYDERABAD, India, Dec. 1, 2021 /PRNewswire/ -- Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization  (CRO/ CDMO), today announced that the Japanese regulatory...

2021-12-01 09:00 2181

Ascentage Pharma and Innovent Biologics Announce Approval for China's First Third-Generation BCR-ABL TKI Olverembatinib, Marking a Clinical Breakthrough in the Treatment of Chronic Myeloid Leukemia

SUZHOU, China and ROCKVILLE, Md., Nov. 30, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, and Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-...

2021-12-01 08:00 1223
1 ... 307308309310311312313 ... 576